Screener
Pacira BioSciences, Inc. PCRX Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Pacira BioSciences, Inc.’s reported figures.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
FAQ
- What is Pacira BioSciences, Inc.'s net debt?
- Pacira BioSciences, Inc. (PCRX) reported net debt of $266.87M in Q1 2026.
- How has Pacira BioSciences, Inc.'s net debt changed year-over-year?
- Pacira BioSciences, Inc.'s net debt increased by 265.3% year-over-year, from $73.05M to $266.87M.
- What is the long-term trend for Pacira BioSciences, Inc.'s net debt?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s net debt has grown at a 15.2% compound annual growth rate (CAGR), from $128.14M to $259.66M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Pacira BioSciences, Inc.'s net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude